F Ejection Fraction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from F ejection fraction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In F Ejection Fraction Today - Breaking & Trending Today

New Data Question Beta-Blockers Post-MI With Preserved EF

In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI. ....

United States , New Zealand , Wayne Batchelor , Troels Yndigegn , Vascular Institute In Fairfax , University Hospital In Lund , Interventional Council , American College Of Cardiology , American College , New England Journal , University Hospital , Medscape Medical News , Inova Schar Heart , Vascular Institute , Myocardial Infarction , Cv Risk , Cardiovascular Risk , V Risk Factors , Cardiovascular Risk Factors , Cardiovascular Risk Management , Acute Myocardial Infarction , Cute Myocardial Infarct , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Cardiac Surgeries ,

No Net HF Benefit for Interarterial Shunt Device

For an all-comer population with any impairment of LV function, an interarterial shunt device missed the primary endpoint in RELIEVE-HF, but benefit was seen with LVEF less than 40%. ....

United States , New York , Maryn Walsh , Patrickt Ogara , Icahn School Of Medicine At Mount Sinai , American College Of Cardiology , Right Chamber Overload Might Explain Harm , Icahn School , Mount Sinai , American College , Scientific Session , V Wave Ltd , Vincent Hospital , Heart Failure , Rejection Fraction , F Ejection Fraction , Left Ventricular Ejection Fraction , Transplantation Of The Heart , Cardiac Transplantation , Heart Transplantation , Pulmonary Hypertension ,

Who Benefits From Beta Blocker Withdrawal in HFpEF?

A new study suggested indexed left ventricular systolic volume may predict benefit of beta blocker withdrawal in patients with heart failure with preserved ejection fraction. ....

University Of Valencia , Patricia Palau , Heart Failure , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Rejection Fraction , F Ejection Fraction , Left Ventricular Ejection Fraction , Drug Withdrawal , Physical Activity , Stroke Cerebrovascular Accident Cva ,

Positive Topline Results for SEQUOIA-HCM Trial in OHCM

Preliminary results of the pivotal phase 3 trial show benefit of the cardiac myosin inhibitor, aficamten, in obstructive hypertrophic cardiomyopathy. ....

United States , Fadyi Malik , Martins Maron , Tufts University School Of Medicine , Drug Administration , Research Development , National Principal Investigator , National Medical Products Administration , Hypertrophic Cardiomyopathy Center , Quantitative Understanding , Obstruction Impact , Lahey Hospital , Medical Center , Tufts University School , Cytokinetic Executive Vice President , Patients With , Exercise Capacity , Assessment Comparing Aficamten , Cardiac Endpoints , Adults With Nonobstructive , Breakthrough Therapy , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Physical Activity , Rejection Fraction ,

FDA Expands Label for CVRx Barostim System in HF

The Barostim neuromodulation system is now indicated in NYHA class III or class II HF despite guideline-directed medical therapies, with LVEF ≤ 35% and NT-proBNP < 1600 pg/mL. ....

Nadim Yared , Drug Administration , Cvrx Inc , York Heart Association , New York Heart Association , Heart Failure , Cardiovascular Imaging , Ardiac Imaging , V Imaging , Rejection Fraction , F Ejection Fraction , Left Ventricular Ejection Fraction , Clinical Guidelines , Treatment Guidelines , Healthcare And Medical Technology , Ealth And Medical Tech , Ealth And Med Tech , Ealth And Medical Technology , Healthcare Technology , Medical Technology ,